cs@prnpharma.com(877) 862-7796
Premium Rx National logo

Sodium Phosphates - SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE and SODIUM PHOSPHATE, DIBASIC, ANHYDROUS 142 mg / mL; 276 mg / mL Injection 15 mL

Reference details for licensed healthcare facility review and verification.

Sodium PhosphatesNDC Family 00409-7391Sodium Phosphates 142 mg / mL; 276 mg / mL
Brand Name: Sodium PhosphatesDosage: InjectionPackage: 25 Vial, Single-DoseActive IngredientType: Intravenous
NDC 1100409-7391-72
Product NDC00409-7391
Generic Drug NameSODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE and SODIUM PHOSPHATE, DIBASIC, ANHYDROUS
Brand NameSodium Phosphates
ManufacturerHospira, Inc.
Strength142 mg / mL; 276 mg / mL
Dosage FormInjection
Drug TypeIntravenous
Package Quantity25 Vial, Single-Dose
Package Description25 VIAL, SINGLE-DOSE in 1 TRAY (0409-7391-72) / 15 mL in 1 VIAL, SINGLE-DOSE (0409-7391-82)
Active IngredientsSodium Phosphate, Dibasic, Anhydrous; Sodium Phosphate, Monobasic, Monohydrate
Marketing CategoryNDA
Drug shortage information availableReview public shortage history and supporting references below.

Unless explicitly stated in writing, no direct affiliation, sponsorship, or endorsement by individual product manufacturers with Premium Rx National, LLC should be implied. All brand names, trade names, and trademarks are the property of their respective owners and are presented solely for accurate product identification and informational reference.

NDC snapshot

SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE and SODIUM PHOSPHATE, DIBASIC, ANHYDROUS 142 mg / mL; 276 mg / mL Injection is tracked under NDC 00409-7391-72 and rolls up into product family 00409-7391. Use this page to review package-level identifiers before comparing related family pages or starting a quote review.

  • Package configuration: 25 Vial, Single-Dose.
  • Manufacturer: Hospira, Inc..
  • Dosage form: Injection.
  • Family size: 1 indexed presentation.

Click a tag to refine the catalog view around this product reference.

NDC Family 00409-7391Presentation: Sodium Phosphates 142 mg / mL; 276 mg / mLDosage: InjectionPackage: 25 Vial, Single-Dose
Review the generic familySodium Phosphates

Official references

Use official labeling and directory references to confirm presentation details while your team reviews the PRN catalog entry and related sourcing paths.

Search DailyMed labelingOpens DailyMed search results.

Potential alternatives with matching presentation

Open the comparison hub or review package-level listings from 3 product-NDC families with matching normalized presentation details. Review each product detail page before treating any item as a true alternative.

View Potential Alternative Hubsodium phosphate, monobasic, monohydrate and sodium phosphate, dibasic, anhydrous 142 mg / mL; 276 mg / mL Injection 15 mL Vial3 package-level listings in the comparison hub.

Sample package-level pages in this comparison set

Sodium Phosphates - Sodium phosphate, monobasic, monohydrate and sodium phosphate, dibasic anhydrous 142 mg / mL; 276 mg / mL Injection 15 mLNDC 00517-7315-25 | 25 Vial, Single-Dose | American Regent, Inc.Sodium Phosphates - Sodium phosphate, monobasic, monohydrate and sodium phosphate, dibasic, anhydrous 142 mg / mL; 276 mg / mL Injection 15 mLNDC 63323-0881-16 | 25 Vial, Single-Dose | Fresenius Kabi USA, LLC

Drug Shortage Information

Shortage summary

This NDC appeared in documented shortage listings in 2016 and 2021, a recurring history that suggests elevated future supply risk.

Product-Specific History

  • Source: FDA shortage query for Dexamethasone Sodium Phosphate Injection

    • Resolved as of October 2024NDC-level public reference
      Listed: August 2021

      Listed as an available product within a shortage-related public source

    • Resolved as of December 2020NDC-level public reference
      Listed: March 2016

      Listed as an available product within a shortage-related public source

Drug Shortage Index family

View Sodium phosphate, monobasic, monohydrate and sodium phosphate, dibasic, anhydrous in the Drug Shortage IndexCompare related NDC-level product references and family-level shortage context for Sodium phosphate, monobasic, monohydrate and sodium phosphate, dibasic, anhydrous.

Related Shortage Navigation

Sodium Phosphates generic family pageBrowse all visible Sodium Phosphates catalog presentations in the broader generic family.

Source: Public FDA drug shortage records accessed through FDA-owned openFDA drug shortages queries.

This section is intended to help healthcare teams review public shortage history and related availability references for this product. Supply conditions can change quickly across manufacturers, distributors, and care settings, and these references may not reflect the latest market status. Premium Rx National does not guarantee completeness or suitability for clinical, operational, or purchasing decisions. Please confirm current availability with FDA, manufacturers, and other authoritative sources before relying on this information.

Sodium Phosphates - SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE and SODIUM PHOSPHATE, DIBASIC, ANHYDROUS 142 mg / mL; 276 mg / mL Injection 15 mL, NDC 00409-7391-72, is a Hospira, Inc. 142 mg / mL; 276 mg / mL injection presentation packaged as 25 Vial, Single-Dose. Historical public shortage information is available for this product reference.

NDC search formats

  • Canonical NDC 11: 00409-7391-72
  • Digits-only NDC 11: 00409739172
  • Possible 10-digit display format: 0409-7391-72 (0409739172)

Helpful product links

  • Search by brand name: Sodium Phosphates
  • NDC 11: 00409-7391-72
  • Product family NDC: 00409-7391
  • VA classification code: TN475
  • VA classification code description: PHOSPHORUS
  • CMOP ID: P1018
  • VUID: 4006291
  • UNSPSC code: 51171622
  • Misc. Order Numbers: 337171